PEDIATRIC CARDIOMYOPATHIES: CONGENITAL CARDIOMYOPATHIES AND MANAGEMENT IN NEONATES AND CHILDREN

View at publisher Summarise with VIRAT
Authors: Süha Asal
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pediatric cardiomyopathies represent a heterogeneous group of myocardial disorders that primarily affect neonates and children, often manifesting as congenital conditions with significant implications for cardiac function and overall prognosis. These disorders encompass dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), left ventricular noncompaction (LVNC), and arrhythmogenic right ventricular cardiomyopathy (ARVC), each characterized by distinct pathophysiological mechanisms rooted in genetic, metabolic, or developmental anomalies. Congenital cardiomyopathies arise from intrinsic myocardial abnormalities, frequently linked to genetic mutations affecting sarcomeric proteins, ion channels, or metabolic pathways, and they differ markedly from acquired forms seen in older populations. In neonates and infants, these conditions may present with subtle signs such as feeding difficulties, tachypnea, or failure to thrive, progressing to overt heart failure if undiagnosed. Etiologically, many cases are familial, with autosomal dominant inheritance predominant in HCM and LVNC, while mitochondrial disorders and inborn errors of metabolism contribute to multisystem involvement. Clinical presentation varies by subtype: DCM often leads to ventricular dilation and systolic dysfunction, resulting in congestive heart failure; HCM features asymmetric septal hypertrophy with potential outflow obstruction; RCM impairs diastolic filling, causing pulmonary hypertension; LVNC involves trabeculated myocardium predisposing to thromboembolism; and ARVC involves fibrofatty replacement of right ventricle, predisposing to arrhythmias. Diagnosis relies on multimodal imaging, including echocardiography for initial assessment, cardiac magnetic resonance imaging (CMR) for tissue characterization, and genetic testing to identify causative variants, which is crucial for family screening. Management in neonates and children includes supportive care, pharmacological interventions like angiotensin converting enzyme inhibitors for DCM or beta-blockers for HCM, device therapy such as implantable cardioverter-defibrillators for arrhythmogenic risks, and advanced options including mechanical circulatory support or heart transplantation in refractory cases. Early intervention is pivotal, as pediatric cardiomyopathies carry a high morbidity burden, with up to 40% of affected children requiring transplantation within five years of diagnosis. This chapter delineates the etiology, clinical features, diagnostic approaches, and tailored management strategies for these congenital entities, underscoring the need for multi-disciplinary care to optimize outcomes in this vulnerable population. It highlights evolving paradigms that hold promise for improved precision in neonatal and childhood management by integrating recent advances in genomic medicine and imaging.

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Cardiovascular Effects of Exercise Viral Infections and Immunology Research

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
115–124
Publication date
1 January 2026
Language
EN
Document type
Book chapter